Jane Street’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SFCM
Jane Street's MTRI Position: Q3 2026 in Review
Jane Street increased its Mentari Therapeutics, Inc. Common Stock (MTRI) stake by 23% in Q3 2026, buying an estimated $14.5K and bringing the position to 5,295 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #10788.
Jane Street first reported a position in MTRI in Q4 2025 and has held it in 3 quarters since. 16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.
- Jane Street held 5,295 shares of Mentari Therapeutics, Inc. Common Stock worth $72K as of Q3 2026.
- Jane Street bought 987 Mentari Therapeutics, Inc. Common Stock shares in Q3 2026, an estimated $14.5K.
- Mentari Therapeutics, Inc. Common Stock made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #10788 holding.
- Jane Street first reported a position in Mentari Therapeutics, Inc. Common Stock in Q4 2025 and has held it in 3 quarters since.
- 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.